guest ::
| Home > Publications database > Mirror image phage display - a method to generate D-peptide ligands for use in diagnostic or therapeutical applications? > print |
| Home > Publications database > Mirror image phage display - a method to generate D-peptide ligands for use in diagnostic or therapeutical applications? > print |
| 001 | 6513 | ||
| 005 | 20200402205709.0 | ||
| 024 | 7 | _ | |2 pmid |a pmid:19603110 |
| 024 | 7 | _ | |2 DOI |a 10.1039/b904138a |
| 024 | 7 | _ | |2 WOS |a WOS:000268033800001 |
| 024 | 7 | _ | |a altmetric:21802855 |2 altmetric |
| 037 | _ | _ | |a PreJuSER-6513 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 540 |
| 084 | _ | _ | |2 WoS |a Biochemistry & Molecular Biology |
| 100 | 1 | _ | |0 P:(DE-Juel1)VDB65869 |a Funke, S. A. |b 0 |u FZJ |
| 245 | _ | _ | |a Mirror image phage display - a method to generate D-peptide ligands for use in diagnostic or therapeutical applications? |
| 260 | _ | _ | |a Cambridge |b Royal Society of Chemistry |c 2009 |
| 300 | _ | _ | |a 783 - 786 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |0 20661 |a Molecular BioSystems |v 5 |x 1742-206X |y 8 |
| 500 | _ | _ | |a This work has been supported by a grant of the Volkswagen-Stiftung to D. W. (I/82 649) and by a grant from the "Prasidentenfond der Helmholtzgemeinschaft'' (HGF, "Virtual Institute of Structural Biology'') to D. W. |
| 520 | _ | _ | |a Mirror image phage display is a straightforward approach to identify new potentially therapeutically active D-enantiomeric peptides. Such D-peptides are more resistant to proteolytic degradation compared to L-peptides. In this review, several examples of mirror image phage display derived D-peptides with therapeutical potential are introduced and discussed. |
| 536 | _ | _ | |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF) |a Funktion und Dysfunktion des Nervensystems |c P33 |x 0 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
| 650 | _ | 2 | |2 MeSH |a Drug Design |
| 650 | _ | 2 | |2 MeSH |a Ligands |
| 650 | _ | 2 | |2 MeSH |a Peptide Library |
| 650 | _ | 2 | |2 MeSH |a Peptides: chemistry |
| 650 | _ | 2 | |2 MeSH |a Peptides: therapeutic use |
| 650 | _ | 2 | |2 MeSH |a Stereoisomerism |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Ligands |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Peptide Library |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Peptides |
| 650 | _ | 7 | |2 WoSType |a J |
| 700 | 1 | _ | |0 P:(DE-Juel1)132029 |a Willbold, D. |b 1 |u FZJ |
| 773 | _ | _ | |0 PERI:(DE-600)2188635-0 |a 10.1039/b904138a |g Vol. 5, p. 783 - 786 |p 783 - 786 |q 5<783 - 786 |t Molecular BioSystems |v 5 |x 1742-206X |y 2009 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1039/b904138a |
| 909 | C | O | |o oai:juser.fz-juelich.de:6513 |p VDB |
| 913 | 1 | _ | |0 G:(DE-Juel1)FUEK409 |a DE-HGF |b Gesundheit |k P33 |l Funktion und Dysfunktion des Nervensystems |v Funktion und Dysfunktion des Nervensystems |x 0 |
| 914 | 1 | _ | |y 2009 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed |
| 920 | 1 | _ | |0 I:(DE-Juel1)VDB942 |d 31.12.2010 |g ISB |k ISB-3 |l Strukturbiochemie |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)114825 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| 981 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|